Researchers have created a novel immunotherapy for metastatic kidney cancer that could provide a new treatment option for ...

The FDA granted orphan drug designation to ligufalimab for AML, reflecting its potential as an immune-based therapy that may ...

Having been through two bouts of breast cancer, I am happy to be on this planet with my family, friends and neighbors.

I reflect on how my family and friends showed love in different ways during the early days of my chronic cancer diagnosis.

For patients with advanced GIST Gleevec, complete surgical removal of metastasis and complete Gleevec response are associated with survival time doubling.

Bob Lane, a prostate cancer survivor and patient receiving Erleada (apalutamide), understands firsthand the challenges men face when discussing prostate cancer. In a previous interview with CURE, Lane ...

Dr. Prithviraj Bose discusses how patients with myelofibrosis can better understand their options and access the most up-to-date advancements in care.